Board Appointments, Ratings Upgrade, Successful Deployments, Submissions, and Conferences - Research Report on Health Care REIT, Ventas, Masimo, Dynavax, and Magellan
NEW YORK, December 24, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting Health Care REIT, Inc. (NYSE: HCN), Ventas, Inc. (NYSE: VTR), Masimo Corporation (NASDAQ: MASI), Dynavax Technologies Corporation (NASDAQ: DVAX), and Magellan Health Services, Inc. (NASDAQ: MGLN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Health Care REIT, Inc. Research Report
On December 18, 2013, Health Care REIT, Inc. (Health Care REIT) announced that Timothy J. Naughton, Chairman, CEO, and President of AvalonBay Communities, Inc., has been named to the Company's Board of Directors. George L. Chapman, Chairman and CEO of Health Care REIT commented, "Tim is a well-known, highly-regarded leader in the REIT and multi-family housing industries. As the current CEO of a leading, publicly-traded REIT, Tim will bring unique, strategic insight gleaned from being the leader of one of the most progressive, well-managed companies in a comparable real estate sector." Health Care REIT informed that Mr. Naughton has more than 20 years of experience in the REIT and commercial real estate sectors. The Full Research Report on Health Care REIT, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: k
http://www.analystscorner.com/r/full_research_report/cf1e_HCN
--
Ventas, Inc. Research Report
On December 17, 2013, Ventas, Inc. (Ventas) announced that Standard & Poor's Ratings Services (S&P) has upgraded the Company's senior unsecured debt rating to BBB+ from BBB, with a stable outlook. Ventas stated that S&P noted in its upgrade the Company's "current and projected strong coverage measures that are supported by stable cash flow". Ventas Chairman and CEO Debra A. Cafaro commented, "We are extremely pleased that S&P has recognized the financial strength and flexibility of our Company, as well as the excellent performance of our large and diversified portfolio." The Full Research Report on Ventas, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/3b95_VTR
--
Masimo Corporation Research Report
On December 19, 2013, Masimo Corporation (Masimo), along with Children's Hospital St. Elisabeth in Neuburg, announced that the hospital has installed in Germany Masimo Patient SafetyNet[TM] system, a remote monitoring and clinician notification system to keep patients safer. Carmen Bauer, Head Nurse of Ward 15 at the Children's Hospital stated, "With Masimo Patient SafetyNet covering 40 beds on two general children wards, we are now able to feel absolutely safe for our patients. We have observed that it's especially beneficial for our most vulnerable patients, who potentially suffer from respiratory depression. And, our staff has been extremely satisfied with the system." The Company informed that the installation includes Masimo SET® measure-through Motion and Low Perfusion pulse oximetry technology, as well as rainbow® Acoustic Monitoring (RAM). The Full Research Report on Masimo Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/6e22_MASI
--
Dynavax Technologies Corporation Research Report
On December 19, 2013, Dynavax Technologies Corporation (Dynavax) announced that it has submitted its responses to the Day 120 List of Questions during Q4 2013. The Company informed that the Day 120 List of Questions was issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) regarding the Company's Marketing Authorization Application (MAA) for HEPLISAV investigational adult hepatitis B vaccine. Dynavax stated that it expects to receive the EMA Day 180 List of Outstanding Issues in Q1 2014. The Full Research Report on Dynavax Technologies Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/b180_DVAX
--
Magellan Health Services, Inc. Research Report
On December 19, 2013, Magellan Health Services, Inc. (Magellan) announced its participation at the 32nd Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco. According to the Company, Barry M. Smith, CEO of Magellan, is scheduled to present on January 14, 2014 at 2:00 p.m. PST / 5:00 p.m. EST. The Company informed that the conference audio and presentation materials can be accessed through the investor relations page of its website. The Full Research Report on Magellan Health Services, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.analystscorner.com/r/full_research_report/4b85_MGLN
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
Share this article